Business Wire - Multimedia Available: FDA Approves SINGULAIR For Seasonal Allergic Rhinitis
Friday, October 3rd, 2008 Health & Pharmaceutical Writers
ADVISORY…for Thursday (Jan. 3)
NOTE TO EDITORS: Multimedia Assets Available With This Story
Include Photos, Text News Releases
–(BUSINESS WIRE)
Merck & Co. Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the leukotriene blocker SINGULAIR(R) (montelukast sodium) for the relief of symptoms of seasonal allergic…
